S&P 500 Technology Sector SEC Filings — May 29, 2026

29-05-2026

Community West Bancshares held its Annual Meeting on May 27, 2026, with 72.23% of outstanding shares represented. All 13 director nominees were elected, and shareholders ratified the appointment of Baker Tilly LLP as independent auditor with overwhelming support (99.9% of votes cast). However, the non-binding advisory resolution on executive compensation received notable opposition, with 876,079 votes against (5.4% of votes cast) and 60,855 abstentions, indicating some shareholder dissent on pay practices.

• · Daniel J. Doyle received the lowest support among director nominees with 12,913,074 votes for and 3,292,881 votes withheld (20.3% withheld).
• · Kirk B. Stovesand also had significant withheld votes: 123,883 against 13,053,991 for (0.9% withheld).
• · All director elections had 3,372,885 broker non-votes, representing about 17.2% of shares represented.
• · The advisory compensation resolution had 15,269,021 votes for, 876,079 against, and 60,855 abstentions, plus 3,372,885 broker non-votes.
• · The auditor ratification had no broker non-votes, with 19,556,109 for, 12,393 against, and 10,338 abstentions.

29-05-2026

KLA-iBotics Holdings Ltd, a BVI holding company with operations in Hong Kong, filed an F-1 registration statement for an initial public offering of 6,250,000 Class A ordinary shares at an expected price range of $4.00 to $6.00 per share, with plans to list on NYSE American. The company is a controlled company, with Kamui Development Group Limited (a subsidiary of Reitar Logtech, listed on Nasdaq) holding 100% of Class B shares representing approximately 88.09% of total voting power. However, the company faces significant risks, including extreme customer concentration—96.8% and 93.1% of total revenue for the two years ended March 31, 2025 and 2024, respectively, came from one affiliated customer, Kamui Construction & Engineering Group Limited—and that customer generated no revenue for the six months ended September 30, 2025 as the relevant project was completed.

• · The company is an emerging growth company as defined under Rule 405 of the Securities Act.
• · The company intends to apply to list on NYSE American under a symbol to be determined.
• · Each Class A ordinary share is entitled to one vote; each Class B ordinary share is entitled to twenty votes and is convertible into one Class A share.
• · The company is a BVI holding company with no material operations of its own; operations are conducted through Hong Kong subsidiaries.
• · The company does not have a VIE structure and does not intend to establish one.
• · The auditor, Enrome LLP, is located in Singapore and is inspected by the PCAOB on a regular basis.
• · The company is subject to risks under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect its auditor for two consecutive years.
• · The company may face restrictions on cross-border transfers of cash or assets from Hong Kong subsidiaries due to PRC government interventions.

29-05-2026

Apple Hospitality REIT, Inc. filed an 8-K on May 29, 2026, disclosing an updated investor presentation containing operating statistics for April and May 2026. The presentation is furnished as Exhibit 99.1 and is intended for use at upcoming conferences and meetings. The filing is a Regulation FD disclosure and does not contain detailed financial results or period-over-period comparisons.

• · The investor presentation was made available on the company's website on May 29, 2026.
• · The presentation includes operating statistics for April and May 2026.
• · The filing is furnished under Items 7.01 and 9.01 of Form 8-K and is not deemed filed for Exchange Act purposes.

29-05-2026

Oxford Square Capital Corp. dismissed PricewaterhouseCoopers LLP (PwC) as its independent auditor and engaged Ernst & Young LLP (EY), effective May 26, 2026. The change was approved by the board based on the audit committee's recommendation. PwC's audit reports for fiscal years 2024 and 2025 were unqualified, and there were no disagreements or reportable events during the relevant periods.

• · The decision to change auditors was made on May 26, 2026, and the 8-K was filed on May 29, 2026.
• · PwC's audit reports for fiscal years ended December 31, 2025 and 2024 were unqualified and contained no adverse opinion or disclaimer.
• · There were no disagreements or reportable events between the company and PwC during the two most recent fiscal years and the subsequent interim period through May 26, 2026.
• · The company had not consulted with EY on any accounting principles or audit opinion matters prior to engagement.

29-05-2026

Aditxt, Inc. (ADTX) received a Nasdaq Staff letter on May 27, 2026, notifying it of non-compliance with the minimum stockholders' equity requirement of $2.5 million, reporting negative equity of $(35,174,386) as of March 31, 2026. This adds to a prior delisting determination based on the minimum bid price rule, with a hearing scheduled for June 11, 2026. The company also acknowledges it is currently not in compliance with the minimum Market Value of Publicly Held Shares requirement of $1,000,000, though no formal notification has been received yet.

• · The company's stockholders' equity was $(35,174,386) as of March 31, 2026, far below the $2.5 million minimum.
• · The company also fails the alternative listing standards: market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recent fiscal year or two of the last three.
• · A prior delisting determination was received on May 6, 2026, for failure to comply with the minimum bid price requirement and ineligibility for a compliance period due to reverse stock split history.
• · The hearing before the Nasdaq Hearings Panel is scheduled for June 11, 2026.
• · The company is also currently not in compliance with the minimum Market Value of Publicly Held Shares of $1,000,000, though no formal notification has been received yet.
• · The Panel has broad discretion to delist the company based on factors including reverse stock split history, financial condition, going concern, capital structure, and capital-raising activities.

29-05-2026

Immunic, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting of stockholders, scheduled for June 29, 2026. The filing details the election of three Class III directors (Thorvald Nagel, Dr. Richard Rudick, and Michael Bonney) and notes that CEO Dr. Daniel Vitt resigned effective June 1, 2026, but will remain on the board to oversee scientific strategy. The board consists of ten members, eight of whom are independent, and the company has adopted a staggered board structure with three-year terms.

• · The annual meeting is scheduled for June 29, 2026.
• · Stockholder proposals for the 2027 annual meeting must be submitted according to deadlines described in the proxy statement.
• · The company uses 'householding' to deliver a single copy of proxy materials to stockholders sharing an address.
• · A list of stockholders entitled to vote will be available at the meeting and from the corporate secretary for ten days prior.
• · Dr. Daniel Vitt resigned as CEO effective June 1, 2026, but remains on the board for scientific strategy.
• · Dr. Duane Nash served as Chairman from April 2019 to December 2025 and as Executive Chairman from April 2020 to December 2025.
• · Michael Bonney previously led Cubist Pharmaceuticals, which was acquired by Merck for $9.5 billion.
• · Thorvald Nagel joined the board in February 2026 and is an analyst at BVF.
• · Dr. Jon Congleton joined the board in 2026 as a continuing Class II director.

29-05-2026

Entravision Communications Corporation (EVC) held its 2026 annual meeting on May 28, 2026, where stockholders elected seven directors, ratified Deloitte & Touche as auditor for FY2026, approved non-binding executive compensation, and approved an amendment to the 2004 Equity Incentive Plan increasing shares authorized by 6,000,000. While the executive compensation advisory vote passed with about 83.5% of votes cast in favor, the equity plan amendment was approved by a narrower margin with only 70.1% of votes cast in favor; director Fehmi Zeko received a relatively high 17.1% withhold vote, indicating some investor dissent.

• · The equity plan amendment was approved with 43,546,376 FOR vs 18,546,733 AGAINST (70.1% in favor of votes cast, excluding broker non-votes).
• · Executive compensation advisory vote: 51,920,969 FOR, 10,171,084 AGAINST, 23,085 abstentions (83.6% in favor of votes cast).
• · Ratification of Deloitte & Touche passed overwhelmingly: 71,402,716 FOR, 158,992 AGAINST, 21,396 abstentions.
• · Director Fehmi Zeko received the highest withhold vote tally among directors: 10,654,102 withheld (17.1% of votes cast, excluding broker non-votes).
• · All other directors received over 97% support among votes cast excluding broker non-votes.

29-05-2026

Mullaney, Keating & Wright, Inc. reported its 13F-HR filing for the period ending December 31, 2024, disclosing a total portfolio value of approximately $148.1 million across 60 equity positions. The filing shows a diversified portfolio with significant allocations to iShares ETFs (including Russell 1000, Mid-Cap, and Value ETFs), Sherwin-Williams, and Vanguard inflation-protected securities. No prior-period comparison data is available in this filing, so period-over-period changes cannot be assessed.

• · Top holdings by value include iShares Russell 1000 ETF ($16.9M), iShares Russell Mid-Cap ETF ($8.2M), iShares Russell 2000 Value ETF ($4.7M), iShares Russell Mid-Cap Value ETF ($5.7M), and Sherwin-Williams ($5.5M).
• · The firm holds a significant position in Vanguard Short-Term Inflation-Protected Securities Index Fund ($6.0M).
• · Apple Inc. is the largest single-stock holding by value ($53.6M), followed by Microsoft ($1.1M) and Exxon Mobil ($0.7M).
• · The filing includes multiple Dimensional ETF Trust funds with combined value exceeding $2.5M.
• · No options or convertible securities are reported; all positions are common stock or ETF shares.

29-05-2026

Replimune Group issued a press release on May 29, 2026, announcing that following collaborative communications with the FDA, it will resubmit its Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for advanced melanoma. The resubmission marks a regulatory step forward after prior discussions with the agency.

• · The resubmission follows collaborative communications with the FDA.
• · The BLA is for RP1 in combination with nivolumab for the treatment of advanced melanoma.
• · The news release was furnished as Exhibit 99.1 to the Form 8-K.
• · The filing is under Item 7.01 (Regulation FD Disclosure) and is not deemed filed for Section 18 purposes.
• · The report was signed by Sushil Patel, CEO.

29-05-2026

Planet Labs PBC filed definitive additional proxy materials (DEFA14A) on May 29, 2026, relating to its upcoming shareholder meeting. The filing does not contain new financial data or material changes, but serves as supplemental soliciting material for the proxy vote.

• · Filing is a DEFA14A (definitive additional proxy materials) filed on May 29, 2026.
• · No fee required for this filing.

29-05-2026

United Community Banks Inc. (UCB) is providing a weekly update on its pending merger with Peach State Bancshares, Inc., announcing key milestone dates including a legal close in Q3 2026 (subject to regulatory approval) and a conversion scheduled for February 12–16, 2027. The filing introduces Rich Bradshaw, President & CBO, who will visit the Peach State team, and highlights United's community-focused initiatives. No financial figures or performance metrics are disclosed in this communication.

• · Legal close of the merger is targeted for Q3 2026, subject to regulatory approval.
• · Conversion is scheduled for February 12–16, 2027.
• · Rich Bradshaw oversees more than 200 branches across United's six-state footprint.
• · United filed a registration statement on Form S-4 on May 28, 2026, which includes a proxy statement for Peach State shareholders.
• · The SEC has not yet declared the registration statement effective.
• · United's 2026 annual meeting proxy statement was filed on April 1, 2026.

29-05-2026

First Community Corporation filed an 8-K on May 29, 2026, furnishing an investor presentation for the 2026 Performance Trust Capital Connect Conference on June 1-2, 2026. The presentation highlights the January 2026 acquisition of Signature Bank of Georgia, strong loan growth of 13.1% annualized in Q1 2026 (excluding the acquisition), and eight consecutive quarters of net interest margin expansion. However, non-interest bearing deposits declined to 27% of total deposits from 29% a year earlier, and the investment portfolio yield remained low at 3.32%.

• · The company has paid dividends for 97 consecutive quarters with a current yield of 2.11% based on a May 26, 2026 closing price of $30.38.
• · Loan principal cash flows (excluding prepayments) for Q2 2026 are $92.6 million at a weighted average rate of 6.09%; for Q2–Q4 2026 total $214.8 million at 6.02%.
• · Investment portfolio principal cash flows for Q2–Q4 2026 are $44.4 million at a weighted average rate of 3.94%.
• · The investment portfolio has an average life of 5.2 years and effective duration of 3.3 years.
• · Non-interest bearing deposits remained flat at 27% of total deposits from Q4 2025 to Q1 2026, but declined from 29% in Q4 2023.
• · Total deposits grew to $2,148.1 million at Q1 2026, including $229.8 million from the Signature Bank acquisition.
• · The company's leverage ratio (bank) and total capital ratio (bank) are shown in the presentation but specific values are not provided in the text.
• · Tangible book value and tangible common equity data are presented in the slides but exact figures are not included in the extracted text.
• · The company received Preferred Lender Status from the SBA on April 10, 2026.
• · GGL loan portfolio size: $52.6 million in loans held-for-investment and $0.6 million in loans held-for-sale.
• · Core net income and EPS for Q1 2026 are shown in thousands on slide 48, but exact figures are not provided in the extracted text.

29-05-2026

Autodesk reported strong Q1 FY27 results with total net revenue of $1,934M, up 18.4% from $1,633M in Q1 FY26, driven by subscription revenue growth of 19.2% to $1,836M. Net income surged to $491M from $152M, a 223% increase, while diluted EPS rose to $2.32 from $0.70. However, operating cash flow improved to $893M from $564M, and the company continued aggressive share repurchases of $448M. Despite the strong top-line growth, restructuring costs remained elevated at $30M, and deferred revenue declined sequentially from $4,693M to $4,457M.

• · Revenue by product family: AECO $970M (+19.9% YoY), AutoCAD $474M (+15.3%), Manufacturing $367M (+18.8%), Media & Entertainment $86M (+13.2%), Other $37M (+32.1%).
• · Revenue by geography: Americas $844M (+16.4%), EMEA $761M (+21.4%), Asia Pacific $329M (+17.1%).
• · Revenue by product type: Design $1,612M (+18.4%), Make $224M (+25.1%), Other $98M (+5.4%).
• · Gross profit margin improved to 90.9% from 90.2%.
• · Operating expenses decreased 1.8% YoY to $1,218M, primarily due to lower restructuring costs ($30M vs $105M).
• · Stock-based compensation expense declined to $155M from $230M.
• · Cash and marketable securities totaled $3,309M at April 30, 2026, up from $2,973M at January 31, 2026.
• · Accounts receivable decreased sharply to $579M from $1,439M sequentially, reflecting strong collections.
• · Goodwill increased to $4,337M from $4,295M, likely due to a business combination.
• · The company had $2,484M in long-term notes payable, essentially unchanged from $2,483M.

29-05-2026

ACADIA Pharmaceuticals held its 2026 Annual Meeting on May 29, 2026, where stockholders elected three Class I directors (James M. Daly, Edmund P. Harrigan, M.D., Adora Ndu, Pharm.D., J.D.) and approved an amendment to the 2024 Equity Incentive Plan to increase authorized shares by 5,209,670. All management proposals, including the advisory vote on executive compensation and ratification of Ernst & Young as independent auditor, were approved with strong majority support.

• · All three Class I director nominees were elected; Edmund P. Harrigan received the lowest support (128,460,130 FOR vs 21,988,617 WITHHELD).
• · Advisory vote on executive compensation passed with 148,265,173 FOR and only 1,911,358 AGAINST.
• · Ernst & Young was ratified as independent auditor for FY2026 with 157,409,378 FOR (98% of votes cast excluding broker non-votes).
• · The 2024 Equity Incentive Plan amendment was approved to increase authorized shares by 5,209,670 shares.
• · The amendment allows issuance of shares under the Plan for equity-based compensation.

29-05-2026

Snowflake Inc. reported revenue of $1.391B for the three months ended April 30, 2026, a 33.5% increase from $1.042B in the same period last year. Net loss narrowed to $295.6M from $430.1M, and operating loss improved to $326.2M from $447.3M. However, cash and cash equivalents declined sharply to $2.085B from $2.828B at January 31, 2026, and the company's accumulated deficit widened to $10.090B from $9.494B.

• · Gross profit increased to $926.5M from $693.3M YoY.
• · Sales and marketing expenses rose to $589.0M from $458.6M YoY.
• · Research and development expenses increased to $534.9M from $472.4M YoY.
• · General and administrative expenses decreased to $128.7M from $209.6M YoY.
• · Interest income fell to $41.1M from $53.2M YoY.
• · Other expense, net improved to $9.6M from $28.1M YoY.
• · Asset impairment related to office facility exits was $17.7M in Q1 FY27 vs $106.5M in Q1 FY26.
• · Accounts receivable decreased by $747.2M (source of cash) vs $393.7M in prior year.
• · Deferred revenue decreased by $528.5M (use of cash) vs $271.4M in prior year.
• · Goodwill increased to $1.537B from $1.194B due to a business combination.
• · Intangible assets, net increased to $451.4M from $246.9M.
• · Convertible senior notes, net remained stable at $2.282B.
• · Total assets decreased to $8.554B from $9.132B.
• · Total liabilities decreased to $6.615B from $7.208B.
• · Stockholders' equity increased slightly to $1.940B from $1.924B.